ARQIS has advised ArchiMed on the acquisition of Germany’s Zyto Group of cancer diagnostics companies in partnership with owners and management. With ArchiMed’s backing, the group is expected to rapidly become a European leader in diagnostics for cutting-edge, precision medical treatments for cancer.
The Business Angels Netzwerk Deutschland e.V. (BAND) sees more shadow than light in the draft Fund Location Act, on which the Federal Ministry of Finance has conducted a written hearing.
ARQIS has advised Munich-based Urban Air Mobility start-up D3 Technologies AG on its Seed II funding round.
The publishing house Iurratio has awarded ARQIS as one of the best employers for legal traineeships in Germany. In the recently published issue Ref50 for 2021, our law firm is recommended in a nationwide comparison as well as specifically for Düsseldorf and Munich.
Financial YearBook Private Equity & Corporate Finance Germany/EU 2021
ARQIS has advised Emergence Therapeutics AG, a European life sciences startup, on its bumped-up follow-on seed round financing.
ARQIS has advised the shareholders of Kroha GmbH on the sale of the company to the AR Packaging Group. After approval by the responsible antitrust authorities, the transaction was completed on 30 November 2020.
ARQIS has advised SkyFive AG on its Pre-Series A financing round, led by a major German investor.
ARQIS has advised Bübchen Skincare GmbH (wholly-owned subsidiary of Katjes International GmbH & Co. KG) on the participation in the start-up Blaue Helden.
Dr. Christof Alexander Schneider talks about D&O insurance in an interview with the German Private Equity and Venture Capital Association.
